Want to join the conversation?
$XLNX's research and development spending fell 6% in 2Q16 from last year, primarily due to lower mask and wafer expenses related to the tape-out timing of its next generation product development. $XLNX plans to continue to selectively invest in R&D efforts in certain areas.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.
$RAI has received a $47 billion take over offer from British tobacco giant British American Tobacco! This is huge!
No better outlook on $MSFT. Even if the results beat a bit, the stock may move 4 to 6% higher, but won't go above $60.